Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 9 (2009), Pages 1072-1104
http://dx.doi.org/10.1100/tsw.2009.121
Review Article

Erythropoietin, Forkhead Proteins, and Oxidative Injury: Biomarkers and Biology

1Division of Cellular and Molecular Cerebral Ischemia, Wayne State University School of Medicine, Detroit, MI, USA
2Department of Neurology and Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, MI, USA
3Barbara Ann Karmanos Cancer Institute, Wayne State University, School of Medicine, Detroit, MI, USA
4Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, MI, USA
5Institute of Environmental Health Sciences, Wayne State University School of Medicine, Detroit, MI, USA

Received 12 August 2009; Revised 16 September 2009; Accepted 17 September 2009

Academic Editor: Sergi Ferre

Copyright © 2009 Kenneth Maiese et al.

Citations to this Article [32 citations]

The following is the list of published articles that have cited the current article.

  • Yan Chen Shang, Zhao Zhong Chong, Jinling Hou, and Kenneth Maiese, “Wnt1, FoxO3a, and NF-κB oversee microglial integrity and activation during oxidant stress,” Cellular Signalling, vol. 22, no. 9, pp. 1317–1329, 2010. View at Publisher · View at Google Scholar
  • Pierluigi Ramadori, Ghayyor Ahmad, and Giuliano Ramadori, “Cellular and molecular mechanisms regulating the hepatic erythropoietin expression during acute-phase response: A role for IL-6,” Laboratory Investigation, vol. 90, no. 9, pp. 1306–1324, 2010. View at Publisher · View at Google Scholar
  • Jinling Hou, Zhao Zhong Chong, Yan Chen Shang, and Kenneth Maiese, “FOXO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling,” Molecular and Cellular Endocrinology, vol. 321, no. 2, pp. 194–206, 2010. View at Publisher · View at Google Scholar
  • Michele Buemi, Valentina Donato, and Davide Bolignano, “Erythropoietin: Pleiotropic actions,” Recenti Progressi in Medicina, vol. 101, no. 6, pp. 253–267, 2010. View at Publisher · View at Google Scholar
  • Francis Dumont, and Pierre Bischoff, “Non-erythropoietic tissue-protective peptides derived from erythropoietin: WO2009094172,” Expert Opinion on Therapeutic Patents, vol. 20, no. 5, pp. 715–723, 2010. View at Publisher · View at Google Scholar
  • Jinling Hou, Zhao Zhong Chong, Yan Chen Shang, and Kenneth Maiese, “Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation,” Current Neurovascular Research, vol. 7, no. 2, pp. 95–112, 2010. View at Publisher · View at Google Scholar
  • Zhao Zhong Chong, Yan Chen Shang, Jinling Hou, and Kenneth Maiese, “Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 2, pp. 153–165, 2010. View at Publisher · View at Google Scholar
  • Kenneth Maiese, Zhao Zhong Chong, Jinling Hou, and Yan Chen Shang, “Oxidative stress: Biomarkers and novel therapeutic pathways,” Experimental Gerontology, vol. 45, no. 3, pp. 217–234, 2010. View at Publisher · View at Google Scholar
  • Kenneth Maiese, Yan Chen Shang, Zhao Zhong Chong, and Jinling Hou, “Diabetes mellitus: Channeling care through cellular discovery,” Current Neurovascular Research, vol. 7, no. 1, pp. 59–74, 2010. View at Publisher · View at Google Scholar
  • Zhao Zhong Chong, Yan Chen Shang, Lijie Zhang, Shaohui Wang, and Kenneth Maiese, “Mammalian target of rapamycin Hitting the bull's-eye for neurological disorders,” Oxidative Medicine And Cellular Longevity, vol. 3, no. 6, pp. 374–391, 2010. View at Publisher · View at Google Scholar
  • Dong-Hyuk Park, David J. Eve, Yong-Gu Chung, and Paul R. Sanberg, “Regenerative Medicine for Neurological Disorders,” Thescientificworldjournal, vol. 10, pp. 470–489, 2010. View at Publisher · View at Google Scholar
  • Yan Chen Shang, Zhao Zhong Chong, Shaohui Wang, and Kenneth Maiese, “Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia,” Current Neurovascular Research, vol. 8, no. 4, pp. 270–285, 2011. View at Publisher · View at Google Scholar
  • David J. Eve, Cesar V. Borlongan, and Paul R. Sanberg, “A Showcase of Bench-to-Bedside Regenerative Medicine at the 2010 ASNTR,” The Scientific World JOURNAL, vol. 11, pp. 1842–1864, 2011. View at Publisher · View at Google Scholar
  • Kenneth Maiese, Zhao Zhong Chong, Yan Chen Shang, and Shaohui Wang, “Erythropoietin: New directions for the nervous system,” International Journal of Molecular Sciences, vol. 13, no. 9, pp. 11102–11129, 2012. View at Publisher · View at Google Scholar
  • Guillaume Fond, Alexandra Macgregor, Jérome Attal, Aurore Larue, Marie Brittner, Deborah Ducasse, and Delphine Capdevielle, “Treating patients with schizophrenia deficit with erythropoietin?,” Psychiatry and Clinical Neurosciences, vol. 66, no. 5, pp. 375–382, 2012. View at Publisher · View at Google Scholar
  • Zhao Zhong Chong, Yan Chen Shang, Shaohui Wang, and Kenneth Maiese, “SIRT1: new avenues of discovery for disorders of oxidative stress,” Expert Opinion on Therapeutic Targets, vol. 16, no. 2, pp. 167–178, 2012. View at Publisher · View at Google Scholar
  • Zhao Zhong Chong, Yan Chen Shang, Shaohui Wang, and Kenneth Maiese, “Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin,” Progress in Neurobiology, vol. 99, no. 2, pp. 128–148, 2012. View at Publisher · View at Google Scholar
  • Kenneth Maiese, Zhao Zhong Chong, Shaohui Wang, and Yan Chen Shang, “Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade,” International Journal Of Molecular Sciences, vol. 13, no. 11, pp. 13830–13866, 2012. View at Publisher · View at Google Scholar
  • Zhao Zhong Chong, Shaohui Wang, Yan Chen Shang, and Kenneth Maiese, “Targeting cardiovascular disease with novel SIRT1 pathways,” Future Cardiology, vol. 8, no. 1, pp. 89–100, 2012. View at Publisher · View at Google Scholar
  • Zhao Chong, and Kenneth Maiese, “Mammalian target of rapamycin signaling in diabetic cardiovascular disease,” Cardiovascular Diabetology, vol. 11, no. 1, pp. 45, 2012. View at Publisher · View at Google Scholar
  • Zhao Zhong Chong, Qingqiang Yao, and Hui-Hua Li, “The rationale of targeting mammalian target of rapamycin for ischemic stroke,” Cellular Signalling, vol. 25, no. 7, pp. 1598–1607, 2013. View at Publisher · View at Google Scholar
  • Kenneth Maiese, Zhao Zhong Chong, Yan Chen Shang, and Jinling Hou, “Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus,” The Journal of Clinical Pharmacology, vol. 51, no. 2, pp. 128–152, 2013. View at Publisher · View at Google Scholar
  • Kenneth Maiese, “mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.,” World journal of diabetes, vol. 6, no. 2, pp. 217–24, 2015. View at Publisher · View at Google Scholar
  • Kenneth Maiese, “Erythropoietin and diabetes mellitus.,” World journal of diabetes, vol. 6, no. 14, pp. 1259–73, 2015. View at Publisher · View at Google Scholar
  • Kenneth Maiese, “Programming apoptosis and autophagy with novel approaches for diabetes mellitus,” Current Neurovascular Research, vol. 12, no. 2, pp. 173–188, 2015. View at Publisher · View at Google Scholar
  • Kenneth Maiese, “FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus,” Current Neurovascular Research, vol. 12, no. 4, pp. 404–413, 2015. View at Publisher · View at Google Scholar
  • Kenneth Maiese, “FoxO Proteins in the Nervous System,” Analytical Cellular Pathology, vol. 2015, pp. 1–15, 2015. View at Publisher · View at Google Scholar
  • Yamila Rodríguez Cruz, Manon Strehaiano, Teresita Rodríguez Obaya, Julío César García Rodríguez, and Tangui Maurice, “An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer’s Disease,” Journal of Alzheimer's Disease, pp. 1–18, 2016. View at Publisher · View at Google Scholar
  • Kenneth Maiese, “Erythropoietin and mTOR: A "one-Two Punch" for aging-related disorders accompanied by enhanced life expectancy,” Current Neurovascular Research, vol. 13, no. 4, pp. 329–340, 2016. View at Publisher · View at Google Scholar
  • Kenneth Maiese, “Regeneration in the nervous system with erythropoietin,” Frontiers In Bioscience-Landmark, vol. 21, pp. 561–596, 2016. View at Publisher · View at Google Scholar
  • Murugeswari Ponnalagu, Murali Subramani, Chaitra Jayadev, Rohit Shetty, and Debashish Das, “Retinal pigment epithelium-secretome: A diabetic retinopathy perspective,” Cytokine, vol. 95, pp. 126–135, 2017. View at Publisher · View at Google Scholar
  • Anna Tankiewicz-Kwedlo, Arkadiusz Surażyński, Krystyna Pawlak, Justyna M. Hermanowicz, Wojciech Kwedlo, Dariusz Rożkiewicz, Tomasz Domaniewski, and Dariusz Pawlak, “Erythropoietin enhances the cytotoxic effect of hydrogen peroxide on colon cancer cells,” Current Pharmaceutical Biotechnology, vol. 18, no. 2, pp. 127–137, 2017. View at Publisher · View at Google Scholar